Bartronics launches extended capability RFID solutions for Indian market BIL ties-up with US-based Intelleflex Corporation Hyderabad, December 22, 2008: Bartronics India Limited today re-affirmed its pioneering status in the Automatic Identification and Data Capture (AIDC) technologies Industry by announcing the launch of extended capability Radio Frequency based Identification (RFID) solutions for the Indian market. The technology is being offered in partnership with Intelleflex Corporation, a US based entity, which has been powering solutions in industries such as transportation, agriculture, manufacturing and retail. Applications most amenable for implementation of RFID include equipment and vehicle yard management, high-value asset tracking, reusable container tracking and personnel monitoring. Commenting on the strategic relationship, Bartronics India Ltd Managing Director, Mr Sudhir Rao said “Partnering with Intelleflex, we can now offer extended capability RFID tracking solutions to the Indian market. By delivering these types of solutions, we will be able to better serve our customers in markets like cold-chain distribution and asset tracking. We chose to partner with Intelleflex because they have established themselves as the technology leader in this product category.” Emerging applications of RFID technology depend upon extended capability solutions, with features such as large user memory, long range operation, advanced security architectures, robust performance in difficult RF environments and sensors for environmental data capture of items like temperature exposure. The extended capability is due to the battery-assisted passive RFID, which extends the operating range to 50 meters. Apart from extending the operating range, the features include on-tag memory of 64kb, zonal location finding and advanced security architecture. Further, the cost has been brought down to a fraction of active RFID. The solution offers two other distinct advantages – one is it can be used in a wide variety of challenging environments because it can withstand exposure to the elements including extreme temperature ranges from -40 to +125 degrees Celsius. The second is that the current multi-protocol readers support both types of tags – normal as well as battery-assisted thereby, enabling easy migration paths. Based on the Intelleflex RFID platform, Bartronics is able to offer differentiated RFID tracking solutions and fills a void in the market where standard passive RFID falls short, but the cost of active RFID is too high. Bartronics has already identified ready markets for the new platform and is actively engaged with customers for implementing the mixed tag solutions.
Bartronics launches extended capability RFID solutions for India
December 22nd, 2008 by | No Comments | Filed in NewsCement Dispatches rebound in November
December 20th, 2008 by | No Comments | Filed in UpdatesSECTOR UPDATE by Sharekhan
Cement dispatches for November 2008 grew by 12% year on year (yoy) to 14.43 million metric tonne (MMT). Cumulative dispatches from April to November 2008 rose by 7.4% to 114.70MMT. The growth for the month under review is mainly on the back of low base effect and end of festive season in October 2008.
The utilisation ratio for the month under review stood at 83.3% as against 90.5% a year ago. The significant drop in utilisation yoy is backed by a 19.3% year-on-year (y-o-y) growth in capacity addition. However, the utilisation ratio also declined on a month-on-month (mom) basis due to capacity addition of 0.11MMT during the month.
Among regions, eastern India emerged as the leading cement-consuming region with a growth rate of 21.7%. Northern and central regions registered an impressive growth of 20.2% and 15.9% respectively. After a long period, the growth rate in southern region has slowed down to 7.9%. However, the western region continued to register a negative growth during the month under review.
Among the companies under our coverage, Shree Cement emerged as a pioneer with a robust volume growth of 33.7% yoy to 0.61MMT during the month, mainly on the back of capacity addition. Ultratech Cement and Orient Paper and Industries Ltd (OPIL) have also registered impressive growth of 16.2% and 14.8% respectively. Dispatches of top three players—ACC, Grasim Industries and Ambuja Cement—have also improved significantly to 8.2%, 5.3% and 8.7% yoy respectively.
Cement prices in November 2008 declined across all major cities (Mumbai, Delhi, Kolkata, Chennai and Hyderabad) compared to those in October 2008. The fall in prices was mainly due to cut in excise duty and slowdown in demand from non-trade segment.
Though macro headwinds remain, in terms of slowdown in key user industries (such as real estate and construction) and overall economy, the recent moderation at cost front and positive impact due to surge in the volumes and savings due to recent cut in central value added tax (cenvat) are likely to improve the estimated profitability of cement companies by 8-15% in FY2010. Additionally, as mentioned in our previous note, the valuations are already attractive with most companies trading at 30-60% discount to their replacement cost. The demand growth is likely to be in the range of around 6.9%, against the earlier expectation of 8-9% growth in FY2009. However, some of the companies like Shree Cement and Ultratech Cement will benefit from relatively early commissioning of their capacities and captive power plants.
Sharekhan Eagle eye this week on Lupin
December 20th, 2008 by | No Comments | Filed in Research, UpdatesLupin settles with Schering on Clarinex
Lupin has settled with Schering-Plough all ongoing litigations relating to Desloratadine tablets, the generic version of Schering-Plough’s allergy drug “Clarinex”® tablets used in the treatment of allergy. As per the terms of the settlement, Lupin will be licenced under the relevant Desloratadine patents and free to commercially launch its generic Desloratadine product on July 1, 2012 or earlier in certain circumstances, ahead of the expiry of the relevant patents in December 2014 and July 2019.
Lupin had earlier filed a Paragraph IV certification with the US Food and Drug Administration (USFDA) to launch Desloratadine tablets, contesting that US Patent nos 6,100,274, 7,214,683 and 7,214,684 were either invalid or had not been infringed upon. This had resulted in the subsequent litigations by Schering Corp. and Sepracor.
Lupin
Cluster: Apple Green
Recommendation: Buy
Price target: Rs840
Current market price: Rs577
Sun Pharmaceutical Extends Tender Offer for Taro
December 20th, 2008 by | No Comments | Filed in Politics
Mumbai, India: December, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the Expiration Date of the Tender Offer for the purchase of all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). The Offer will now expired at 5:00 p.m., New York City time, on Friday, January 9, 2009, unless further extended or earlier terminated. The Tender Offer was extended to comply with a continuing order issued by the Supreme Court of Israel temporarily prohibiting the closing of the Offer until the Supreme Court issues a decision on the appeal of the litigation commenced against Alkaloida and its affiliates by Taro and certain of its directors regarding the applicability of the special tender offer rules under the Israeli Companies Law to the Offer. The Tel-Aviv District Court had previously ruled in favor of Sun Pharma that a special tender offer was not required.
On December 8, 2008, the Supreme Court heard oral arguments on the appeal. At the conclusion of the hearing, the Supreme Court instructed the parties to negotiate with one another with the view to reaching a settlement to resolve the dispute and to update the Supreme Court within 30 days as to the result of such negotiations. The Supreme Court indicated that it will render a judgment on the appeal if no agreement is reached. Sun has been engaging in discussions pursuant to the Supreme Court’s instructions. If the temporary order remains in effect on January 9, 2009, Sun expects to extend the Offer while the temporary order remains outstanding.
The Offer was commenced on June 30, 2008 in order to comply with the terms of the Option Agreement between Alkaloida and the controlling shareholders of Taro. Alkaloida exercised its options to acquire shares of Taro from the controlling shareholders on June 25, 2008. The Option Agreement required Alkaloida, promptly after exercising the options, to commence a tender offer at USD 7.75 per Ordinary Share of Taro held by other shareholders. The Offer had previously been scheduled to expire at 5:00 p.m., New York City time, on Friday, December 19, 2008. As of 5:00 p.m., New York City time, on December 18, 2008, 613,936 Ordinary Shares had been tendered and not withdrawn from the Offer.
Shoppers Stop extends its option of acquiring 51% of Hypercity
December 20th, 2008 by | No Comments | Filed in PoliticsMumbai, December 20, 2008: The Company, Promoters of Hypercity Retail (India) Limited (Hypercity), has executed an Option Agreement; whereby the Company has an option to acquire upto 51% of the equity share capital of Hypercity from Promoters at any time prior to December 31, 2008. The Company has already acquired 19% stake in Hypercity in March, 2007.
The Company and Promoters of Hypercity, have decided to extend the aforesaid option of acquiring remaining 32% of Equity Share Capital of Hypercity by Company on the same terms and conditions upto June 30, 2010.
Speaking on extension of option, Mr. B.S.Nagesh – Customer Care Associate and Managing Director, Shoppers’ Stop Ltd. said, “Considering the present scenario, we have requested the Promoters of Hypercity and they have agreed and provided an extension upto June 30, 2010”
DBS Chola MF launches DBS Chola Tax Advantage Fund – Series 1
December 20th, 2008 by | No Comments | Filed in Uncategorized NFO Opens: 19th Dec, 2008; Closes: 19th March, 2009
NewDelhi, December 20, 2008: DBS Chola MF today announced the launch of DBS Chola Tax Advantage Fund – Series 1. The fund is a 10 – year close ended Equity Linked Saving Scheme, subject to a lock in for a period of three years from date of allotment. The objective of the scheme is to seek to generate long-term capital growth from a diversified portfolio of predominantly equity and equity-related securities and also enabling investors to get income tax rebate as per the prevailing Tax Laws and subject to applicable conditions.
Sanjay Sinha, Chief Executive Officer, DBS Cholamandalam Asset Management Ltd. said, “This fund will follow “Value Investing strategy”. Current market conditions favour this strategy as it limits the downside potential of these stocks. In addition to the tax benefit, a 3 year lock-in allows investors to realise a better potential for their investment.”
The minimum amount for Application during the NFO period will be Rs. 500/- and in multiples of Rs. 500 thereafter. The fund would invest between 80- 100% in Indian equities and equity related securities and 0% to 20% in money market instruments / debt securities instruments.
The performance of the Plan will be benchmarked against the BSE 200 Index.
Chanda Kochhar is Managing Director & CEO of ICICI Bank from May 1, 2009
December 19th, 2008 by | No Comments | Filed in PoliticsMumbai, December 19, 2008: Mr. N. Vaghul, non-executive Chairman of the Board of Directors of ICICI Bank Limited (NYSE: IBN) would retire from the Board on completion of his current term on April 30, 2009. The Board has, subject to the approval of Reserve Bank of India (RBI) and the shareholders, decided to appoint Mr. K. V. Kamath, presently Managing Director & CEO, as non-executive Chairman of the Board for a period of five years effective May 1, 2009. Mr. Kamath’s current term as Managing Director & CEO would end on April 30, 2009 and he has expressed his desire to lay down his executive responsibilities from that date.
The Board of Directors has, subject to the approval of RBI and the shareholders, decided to appoint Ms. Chanda D. Kochhar, presently Joint Managing Director & Chief Financial Officer, as Managing Director & CEO of ICICI Bank from May 1, 2009 to March 31, 2014. Ms. Chanda Kochhar joined erstwhile ICICI Limited (ICICI) in 1984 and was elevated to the Board of Directors of ICICI Bank in 2001. During her career prior to becoming a member of the Board, she worked and held leadership positions across all key businesses, including corporate banking, project finance and retail banking. She was instrumental in establishing ICICI Bank during the 1990s, and subsequently headed the infrastructure finance and major clients groups in ICICI. In 2000, she took on the challenge of building the nascent retail business, with strong focus on technology, innovation, process reengineering and expansion of distribution and scale. The Bank achieved a leadership position in this business. She successfully managed the integration of the retail franchises of ICICI and ICICI Bank, as well as of other acquisitions. During 2006-2007, she successfully led the Bank’s wholesale and international banking businesses during a period of heightened activity and global expansion by Indian companies. Since 2007, she has been heading the Corporate Centre, responsible for ensuring strategic consistency across the Group.
The Board expressed the view that Mr. Kamath’s experience and expertise would prove invaluable to the Board in maintaining continuity in strategic leadership and governance and providing guidance to the executive management. The Board expressed the view that Ms. Kochhar’s deep experience across the Bank’s businesses and functions would be invaluable in providing stability while at the same time charting the Bank’s future strategic course in the emerging global environment.
Mr. Kamath said “Chanda has played a key leadership role in all the major strategic initiatives that we have taken. I am sure that the depth of experience, multi-dimensional domain knowledge and strategic thinking that she brings to the role will take the ICICI Group to even greater heights. Team ICICI joins me in wishing her the very best in her new role. ”
Ms. Kochhar said “I would like to thank the Board for the confidence they have reposed in me, and Mr. Kamath for his inspiring leadership. I am committed to working with our team and with all our stakeholders to leverage the ICICI Group’s strengths and capitalize on the opportunities before us. We look forward to Mr. Kamath’s continued mentoring and guidance in the years ahead.”
Upaid Seeks Satyam Top Heads depostion
December 19th, 2008 by | No Comments | Filed in News, UpdatesLondon – UK based Online and mobile payment services company Upaid Systems announced that, it is filing a motion in US court requesting deposition of Satyam Computer Services Chairman B. Ramalinga Raju, Chief Financial Officer V. Srinivas and Global Head of Corporate Governance G. Jayaraman.
Upaid System has issued a press release in this connection on its official website www.upaid.net.
The deposition is for “the attempt earlier this week to strip all surplus cash from the company in a $1.6 bin related-party transaction benefiting the family of Satyam’s founder and Chairman,” the release said.
The Upaid has made the deposition petition available to the public on its website along with its statement.
Satyam is facing suits in U.S. Federal and State Courts filed by Upaid claiming fraud, forgery and breach of contract, as a result of which Upaid has suffered damages to its business and prospects in excess of $1 bln.
The Federal Court proceeding is currently scheduled for a Texas jury trial in June of 2009.
On Tuesday, Satyam Computers has announced to acquire two companies Maytas Infra Ltd and Maytas Properties Ltd for a total some of $ 1.6 bln, however, they dropped the plans following the protest from the investors.
Upaid Systems termed the Satyam move as designed to deplete its assents in advance of a judgment, adding “Satyam may be willing to engage in fraudulent transfers to avoid its legal obligations.”
On Thursday, Satyam Compuer Services Chief Financial officer V. Srinivas said, the company has a cash reserves of 53 bln rupees and deposited in various bank across the world.
At present, Satyam has cash resources to pay a $1 billion plus judgment or the liquidity to support supersede as bond. However, on December 16, 2008, Satyam announced a plan to strip $1.6 billion of cash out of the company, an amount that exceeds its cash, in a transaction to acquire Maytas Properties and Maytas Infra, whereby the large majority of this cash would go to the family of Satyam’s Chairman, Ramalinga Raju. That Satyam would proceed with a transaction that seems so clearly designed to deplete its assets in advance of a judgment, rightfully concerns Upaid that Satyam may be willing to engage in fraudulent transfers to avoid its legal obligations.
Satyam has put its reputation in the business community squarely at issue in court proceedings it has filed against Upaid. The Satyam executives whose depositions are being requested, Ramalinga Raju, (Chairman) Srivinas Valdamani (CFO) and G. Jayaraman, (Global Head – Corporate Governance) are in the best positions to know Satyam’s reputation in the business community and the events that have drawn such widespread criticism in the marketplace as underscored by recent news reports. The evidence of Satyam’s poor corporate governance and business practices has been mounting, harming Upaid, other customers and now Satyam’s shareholders. The Maytas transactions further damaged Satyam’s reputation, sparking widely-reported outrage among Satyam’s shareholders and a fire sale on Satyam’s stock that resulted in a 55 percent one-day decline in the company’s market value.
For More info on Upaid request: http://www.upaid.net/doclib/Collin_County_MotiontoCompelDepositions.pdf
Satyam Computer Services: Reputation damage difficult to undo
December 17th, 2008 by | No Comments | Filed in UpdatesKotak Suspend rating and target price
• Reputation damage difficult to undo
• Concerns on cash utilization still remain—US$430 mn lying in current accounts
baffling
• Potential disruption in the IT services business plausible
• Suspend rating and target price
In a bizarre sequence of events, Satyam proposed and then revoked the proposed
acquisition of its affiliated real estate and infrastructure companies. We believe that the
reputation damage in the minds of all the major stakeholders viz. the non-promoter
shareholders (who hold 90%+ of the company), employees, business partners, and clients
would be difficult to undo. In addition, the negative press that the company would receive
on the event may also negatively impact the cash generating IT services business. We had
previously raised issues about use and deployment of cash especially the increasing
amount of cash balance in current accounts (Rs20 bn at end-2QFY09) (please refer to our
note on Satyam dated Oct 20, 2008) and believe that the market may no longer be
charitable to the company on such issues. We expect a structural de-rating of the stock.
We shall review our estimates and valuation of the company over the next few days in the
light of the event and its potential repercussion on the company’s core business prospects.
In the interim, we suspend rating and target price on the stock.
Reputation damage difficult to undo.
We expect a structural de-rating in the Satyam
stock on account of yesterday’s sequence of events. Revoking the decision to acquire
affiliated group companies under investor pressure would do little to rebuild the lost
confidence of the market in the company’s corporate governance practices.
Concerns on cash utilization still remain- US$430 mn lying in current accounts
baffling.
We believe that the markets would not give any benefit of excess cash in books
(Rs53 bn at end Sep-08). We had raised concerns in the past on Satyam’s cash
management (see Exhibit 1). Our subsequent discussions with the management have
failed to yield satisfactory answers. The management yesterday stated that they have
transferred some of the funds from current accounts to deposit accounts.
Potential disruption in the IT services business plausible.
We believe that serious corporate governance doubts and negative press may impact the perception of the
company amongst the stakeholders i.e. employees, business partners and customers. We
believe that these developments can impact the customer base especially in the current
environment where clients are looking to work with fewer vendors (vendor consolidation).
We are also not sure about We are also not sure about the impact of this on middle and senior management team
especially given that they had been incentivized through stock compensation in the past.
Target for hostile takeover?
Satyam is a widely held company with the promoters holding a mere 8.6%. Exhibit 2 gives the last disclosed shareholding pattern of the company. We would not be surprised to see a concerted effort for management change
and reduction in the power of the Board of Directors. We understand that under section
284 of Companies Act, specific director/directors from the Board of a company can be
removed (before the expiry of his period of office). Also under section 169, 10% or more
of the shareholders (in terms of value of underlying equity) can convene an extraordinary
general meeting to remove a director.
So what really happened?
We were baffled by Satyam’s decision to venture into completely unrelated infrastructure development and real estate businesses by acquiring majority stakes in affiliated companies. We found no synergy between the IT services and
real estate/infrastructure businesses. The proposed acquisition would have resulted in
Satyam having a net debt of about US$400 mn (in addition to potential assumed debt of
acquired entities) versus a current cash balance of US$1.1 bn. Effectively, the entire
funding obligation of the infra/ real estate businesses would have been put on Satyam,
while the promoters would have walked away with large portions of cash. We discuss the
proposed acquisitions (subsequently revoked) below.
1. Maytas Properties. Satyam proposed to pay US$1.3 bn to the founders and other
shareholders to acquire 100% stake. The management failed to elaborate on the
valuation methodology employed, shareholding structure and the bankers used for the
deal. Maytas properties has 6,800 acres of land bank, 245 mn sq ft of developable
space and projected revenues of US$90 mn for FY2009.
2. Maytas Infrastructure. Satyam proposed to acquire 51% stake (31% from promoters,
20% mandatory open offer) for a total consideration of US$300 mn. Maytas Infra is a
listed company with a market cap of US$600 mn. Maytas Infra has an order book of
US$2.5 bn and is involved in construction and infrastructure projects.
Glenmark Confirms Patent Challenge of Fluticasone Lotion
December 17th, 2008 by | No Comments | Filed in News, UpdatesGlenmark Generics Ltd’s US subsidiary(GGI) confirmed Nycomed US (“Nycomed”) filed a patent infringement lawsuit on 12 Dec 2008 in the U.S. District Court, Eastern District Court of New York regarding Glenmark’s Abbreviated New Drug Application (“ANDA”) for its Fluticasone Propionate 0.05% Lotion product. Nycomed currently markets its Fluticasone product as CUTIVATE®.
Glenmark filed its ANDA containing a paragraph IV certification for a generic version of Fluticasone Propionate lotion with the U.S. Food & Drug Administration (FDA), and following receipt of the notice from the FDA that Glenmark’s ANDA had been accepted for filing, Glenmark notified the New Drug Application (NDA) holder and patent owner.
Nycomed’s lawsuit is part of the patent challenge process under the Hatch-Waxman Act. Based on the information published by the FDA, Glenmark believes it may be the first applicant to have filed an ANDA for this product with a paragraph IV certification. In the event that Glenmark successfully challenges Nycomed’s patent, Glenmark will be entitled to a 180-day exclusivity period.
CUTIVATE (Fluticasone Propionate) 0.05% Lotion had annual sales of approximately USD 33 million in the U.S., based on IMS sales data ending September 2008.
With this filing, Glenmark has three products currently under litigation under the Hatch-Waxman Act. The earlier two molecules are Ezetimibe and Trandolapril+Verapamil Hydrochloride . On successful patent challenges, Glenmark will be entitled for the 180 days exclusivity.




